Irma Kirtadze
Overview
Explore the profile of Irma Kirtadze including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
232
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Otiashvili D, Mgebrishvili T, Sherozia M, Alania M, Kirtadze I
Drug Alcohol Rev
. 2025 Feb;
44(3):897-907.
PMID: 39925212
Introduction: Study aimed at exploring the experience of migrants from Russia who use psychoactive substances, who arrived in Georgia in the wake of the invasion of Ukraine. Methods: Qualitative individual...
2.
Mgebrishvili T, Kirtadze I, Mirzazadeh A, Otiashvili D
J Psychoactive Drugs
. 2025 Feb;
:1-10.
PMID: 39918885
The study aims to assess cannabis dependency among individuals who cultivate cannabis for medical and/or recreational purposes. Participants included growers who cultivated cannabis for personal use, social supply, caregiving activities,...
3.
Nadareishvili I, Rao S, Otiashvili D, Gnatienko N, Samet J, Lunze K, et al.
Addiction
. 2024 Oct;
120(2):335-346.
PMID: 39417804
Background And Aim: In 2018, the country of Georgia legalized cannabis for recreational use and decriminalized limited possession. This study aimed to assess whether cannabis use increased among young adults...
4.
Sogaard T, Brummer J, Wilkins C, Sznitman S, Sevigny E, Frank V, et al.
Int J Drug Policy
. 2024 Jun;
:104463.
PMID: 38834441
Background: While the supply of cannabis is commonly assumed to be dominated by criminal gangs, a sizable share of the domestic cannabis supply is provided by small-scale growers. This article...
5.
Sznitman S, Potter G, Grigg J, Granville A, Hakkarainen P, Decorte T, et al.
Int J Drug Policy
. 2023 Dec;
:104263.
PMID: 38087710
Background: Little is known about cannabis use problems among individuals who use cannabis for medical purposes and whether rates and determinants of cannabis use problems in medical users differ to...
6.
Walker J, Kirtadze I, Tabatadze M, Vickerman P, Otiashvili D
Harm Reduct J
. 2023 Aug;
20(1):103.
PMID: 37533020
Background: Syringe vending machines (SVM) can improve access to sterile injecting equipment, but they have not been widely implemented or evaluated. We evaluate the cost of SVM installed between July...
7.
Otiashvili D, Kirtadze I, Mgebrishvili T, Beselia A, Tabatadze M, Vardanashvili I, et al.
Int J Drug Policy
. 2022 Mar;
103:103649.
PMID: 35299004
Background: Syringe vending machines (SVM) have proven to be an effective vehicle for providing an uninterrupted supply of sterile equipment to PWID, but they have not been implemented or disseminated...
8.
Otiashvili D, Mgebrishvili T, Beselia A, Vardanashvili I, Dumchev K, Kiriazova T, et al.
Harm Reduct J
. 2022 Mar;
19(1):25.
PMID: 35264181
Background: This study examines the effects of COVID-19 related restrictions on the supply of illicit drugs, drug-use behaviour among people who use drugs (PWUD) regularly (at least weekly), and drug-related...
9.
Otiashvili D, Kirtadze I, Mgebrishvili T, Beselia A, Tabatadze M, Otiashvili N, et al.
J Stud Alcohol Drugs
. 2021 Nov;
82(6):752-757.
PMID: 34762034
Objective: Syringe vending machines (SVMs) are intended to supplement the standard syringe exchange programs to access hard-to-reach groups and to cover unserved geographical areas. This report describes how we adapted...
10.
Lawlor C, Gogia M, Kirtadze I, Stvilia K, Jikia G, Zurashvili T
Harm Reduct J
. 2021 Jul;
18(1):78.
PMID: 34321004
Background: Georgia has a significant risk of ongoing HIV and HCV outbreak. Within this context, harm reduction aims to reduce risk associated with drug use through community activities, such as...